| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30085360 | HIV | ENSG00000057593.14 | protein_coding | F7 | No | No | 2155 | F5H8B0 P08709 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | F7 |
|---|---|
| DrugBank ID | DB00036 |
| Drug Name | Coagulation factor VIIa Recombinant Human |
| Target ID | BE0000333 |
| UniProt ID | P08709 |
| Regulation Type | |
| PubMed IDs | 10388743; 11735107; 12525826; 15907148; 16370916 |
| Citations | Perera L, Darden TA, Pedersen LG: Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association. Biophys J. 1999 Jul;77(1):99-113.@@Shapiro A: Inhibitor treatment: state of the art. Semin Hematol. 2001 Oct;38(4 Suppl 12):26-34.@@Shapiro A: Inhibitor treatment: state of the art. Dis Mon. 2003 Jan;49(1):22-38.@@Siddiqui MA, Scott LJ: Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders. Drugs. 2005;65(8):1161-77.@@Rizoli SB, Chughtai T: The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage. Expert Opin Biol Ther. 2006 Jan;6(1):73-81. |
| Groups | Approved |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164748389 |
| ChEMBL |
